Carolinas Medical Center is an 874-bed non-profit, tertiary, research and academic medical center located in Charlotte, North Carolina, servicing the southern North Carolina, northern South Carolina, and the Metrolina region.

There are 874 beds in The Charlotte-Mecklenburg Hospital Authority.

During the past decade, The Charlotte-Mecklenburg Hospital Authority conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Charlotte-Mecklenburg Hospital Authority" #1 collaborator was "Austrian Breast & Colorectal Cancer Study Group" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "NSABP Foundation Inc" with 1 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "The Charlotte-Mecklenburg Hospital Authority" are "Atherosclerosis" (1 trials), "Breast Cancer" (1 trials), "Carotid Stenosis" (1 trials), "Cerebral Infarction" (1 trials) and "Myocardial Infarction" (1 trials). Many other conditions were trialed in "The Charlotte-Mecklenburg Hospital Authority" in a lesser frequency.

Most popular intervention types in "The Charlotte-Mecklenburg Hospital Authority" are "Biological" (1 trials), "Device" (1 trials), "Drug" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Carotid Artery Stenting (CAS)" (1 trials), "Carotid Endarterectomy (CEA)" (1 trials), "Ipilimumab" (1 trials), "Palbociclib" (1 trials) and "Standard Adjuvant Endocrine Therapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "The Charlotte-Mecklenburg Hospital Authority" are 2 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "The Charlotte-Mecklenburg Hospital Authority". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in The Charlotte-Mecklenburg Hospital Authority, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in The Charlotte-Mecklenburg Hospital Authority, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".